677 related articles for article (PubMed ID: 26857415)
41. Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study.
Shimada H; Hirano S; Sinotoh H; Ota T; Tanaka N; Sato K; Yamada M; Fukushi K; Irie T; Zhang MR; Higuchi M; Kuwabara S; Suhara T
Int J Geriatr Psychiatry; 2015 Nov; 30(11):1105-13. PubMed ID: 26280153
[TBL] [Abstract][Full Text] [Related]
42. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD.
Lobotesis K; Fenwick JD; Phipps A; Ryman A; Swann A; Ballard C; McKeith IG; O'Brien JT
Neurology; 2001 Mar; 56(5):643-9. PubMed ID: 11245717
[TBL] [Abstract][Full Text] [Related]
43. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias.
Mosconi L; Tsui WH; Herholz K; Pupi A; Drzezga A; Lucignani G; Reiman EM; Holthoff V; Kalbe E; Sorbi S; Diehl-Schmid J; Perneczky R; Clerici F; Caselli R; Beuthien-Baumann B; Kurz A; Minoshima S; de Leon MJ
J Nucl Med; 2008 Mar; 49(3):390-8. PubMed ID: 18287270
[TBL] [Abstract][Full Text] [Related]
44. Differentiation of dementia with Lewy bodies from Alzheimer's disease using Mini-Mental State Examination and brain perfusion SPECT.
Hanyu H; Shimizu S; Hirao K; Kanetaka H; Sakurai H; Iwamoto T; Koizumi K; Abe K
J Neurol Sci; 2006 Dec; 250(1-2):97-102. PubMed ID: 17005204
[TBL] [Abstract][Full Text] [Related]
45. Differentiating Mild Cognitive Impairment, Alzheimer's Disease, and Dementia With Lewy Bodies Using Cingulate Island Sign on Perfusion IMP-SPECT.
Kanetaka H; Shimizu S; Inagawa Y; Hirose D; Takenoshita N; Sakurai H; Hanyu H
Front Neurol; 2020; 11():568438. PubMed ID: 33329310
[TBL] [Abstract][Full Text] [Related]
46. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
Grimmer T; Wutz C; Alexopoulos P; Drzezga A; Förster S; Förstl H; Goldhardt O; Ortner M; Sorg C; Kurz A
J Nucl Med; 2016 Feb; 57(2):204-7. PubMed ID: 26585056
[TBL] [Abstract][Full Text] [Related]
47. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
[TBL] [Abstract][Full Text] [Related]
48. Computer-assisted system for diagnosing degenerative dementia using cerebral blood flow SPECT and 3D-SSP: a multicenter study.
Ishii K; Ito K; Nakanishi A; Kitamura S; Terashima A
Jpn J Radiol; 2014 Jul; 32(7):383-90. PubMed ID: 24838777
[TBL] [Abstract][Full Text] [Related]
49. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB
J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568
[TBL] [Abstract][Full Text] [Related]
50. Brain
Woyk K; Sahlmann CO; Hansen N; Timäus C; Müller SJ; Khadhraoui E; Wiltfang J; Lange C; Bouter C
J Neuroimaging; 2023 Mar; 33(2):256-268. PubMed ID: 36465027
[TBL] [Abstract][Full Text] [Related]
51. Early differentiation of dementia with Lewy bodies and Alzheimer's disease: Heart rate variability at mild cognitive impairment stage.
Kim MS; Yoon JH; Hong JM
Clin Neurophysiol; 2018 Aug; 129(8):1570-1578. PubMed ID: 29883835
[TBL] [Abstract][Full Text] [Related]
52. Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer's disease.
Massa F; Chincarini A; Bauckneht M; Raffa S; Peira E; Arnaldi D; Pardini M; Pagani M; Orso B; Donegani MI; Brugnolo A; Biassoni E; Mattioli P; Girtler N; Guerra UP; Morbelli S; Nobili F
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1263-1274. PubMed ID: 34651219
[TBL] [Abstract][Full Text] [Related]
53. Neuropathological investigation of the hypometabolic regions on positron emission tomography with [18F] fluorodeoxyglucose in patients with dementia with Lewy bodies.
Kasanuki K; Iseki E; Fujishiro H; Yamamoto R; Higashi S; Minegishi M; Togo T; Katsuse O; Uchikado H; Furukawa Y; Hino H; Kosaka K; Sato K; Arai H
J Neurol Sci; 2012 Mar; 314(1-2):111-9. PubMed ID: 22041339
[TBL] [Abstract][Full Text] [Related]
54. FDG-PET for Prediction of AD Dementia in Mild Cognitive Impairment. A Review of the State of the Art with Particular Emphasis on the Comparison with Other Neuroimaging Modalities (MRI and Perfusion SPECT).
Sanchez-Catasus CA; Stormezand GN; van Laar PJ; De Deyn PP; Sanchez MA; Dierckx RA
Curr Alzheimer Res; 2017; 14(2):127-142. PubMed ID: 27357645
[TBL] [Abstract][Full Text] [Related]
55. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
Shimizu S; Hirao K; Kanetaka H; Namioka N; Hatanaka H; Hirose D; Fukasawa R; Umahara T; Sakurai H; Hanyu H
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438
[TBL] [Abstract][Full Text] [Related]
56. Amygdala sign, a FDG-PET signature of dementia with Lewy Bodies.
Pillai JA; Wu G; Tousi B; Larvie M; Léger GC; Leverenz JB
Parkinsonism Relat Disord; 2019 Jul; 64():300-303. PubMed ID: 30905401
[TBL] [Abstract][Full Text] [Related]
57. Biomarkers of Dementia with Lewy Bodies: Differential Diagnostic with Alzheimer's Disease.
Bousiges O; Blanc F
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742814
[TBL] [Abstract][Full Text] [Related]
58. Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.
Cerami C; Della Rosa PA; Magnani G; Santangelo R; Marcone A; Cappa SF; Perani D
Neuroimage Clin; 2015; 7():187-94. PubMed ID: 25610780
[TBL] [Abstract][Full Text] [Related]
59. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain
Nobili F; Arbizu J; Bouwman F; Drzezga A; Agosta F; Nestor P; Walker Z; Boccardi M;
Eur J Neurol; 2018 Oct; 25(10):1201-1217. PubMed ID: 29932266
[TBL] [Abstract][Full Text] [Related]
60. Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia.
Arbizu J; Prieto E; Martínez-Lage P; Martí-Climent JM; García-Granero M; Lamet I; Pastor P; Riverol M; Gómez-Isla MT; Peñuelas I; Richter JA; Weiner MW;
Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1394-405. PubMed ID: 23715905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
